Home › Funds › Palo Alto Investors LP › BNTX

Palo Alto Investors LP position in BNTX

BIONTECH SE · Health Care

Palo Alto Investors LP reported holding 19,614 shares of BNTX (BIONTECH SE) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.29% of its reported portfolio and ranking #42 among its reported holdings. Palo Alto Investors LP has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)19.61K sh
Reported value held$1.93M
Portfolio Weight0.29%
First reportedQ3 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's BNTX position evolved

Palo Alto Investors LP first disclosed a stake in BNTX in Q3 2024 at 25,206 shares (US$3.0M). Across 9 filings, Palo Alto Investors LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 19,614 shares valued at US$1.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 25.21K $2.99M New
Q4 2024 25.21K $2.87M Hold
Q1 2025 25.21K $2.30M Hold
Q2 2025 25.21K $2.68M Hold
Q3 2025 19.61K $1.93M Reduce
Q4 2025 19.61K $1.87M Hold
Q1 2026 19.61K $1.74M Hold
Q2 2026 19.61K $1.83M Hold
Q3 2026 19.61K $1.93M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTX and 13F data

BNTX (BIONTECH SE) is a Health Care company. 30 other funds we track also report a position in BNTX — the largest reported positions include Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M), Logos Global Management LP (US$63.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTX

All BNTX fund holders →

FAQ

How long has Palo Alto Investors LP held BNTX?

Palo Alto Investors LP has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Palo Alto Investors LP's current position in BNTX?

As of Q3 2026, Palo Alto Investors LP holds 19.61K shares of BNTX (BIONTECH SE), valued at $1.93M, representing 0.29% of its reported portfolio and ranking #42.

Has Palo Alto Investors LP been buying or selling BNTX?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in BNTX.

Which other funds hold BNTX?

Other major institutional holders of BNTX include Davern Capital Partners, LP, GSK plc, Logos Global Management LP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.